Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127167003 | 12716700 | 3 | F | 20160718 | 20160906 | 20160906 | 20160914 | EXP | IT-PFIZER INC-2016414308 | PFIZER | 50.00 | YR | F | Y | 0.00000 | 20160914 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127167003 | 12716700 | 1 | PS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 10 MG, UNK | 18276 | 10 | MG | ||||||||
| 127167003 | 12716700 | 2 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 7-8 MG SINGLE, AS NEEDED | 74243 | ||||||||||
| 127167003 | 12716700 | 3 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 127167003 | 12716700 | 4 | C | TRILAFON | PERPHENAZINE | 1 | Oral | 2 MG, UNK | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127167003 | 12716700 | 1 | Drug abuse |
| 127167003 | 12716700 | 2 | Drug abuse |
| 127167003 | 12716700 | 3 | Depression |
| 127167003 | 12716700 | 4 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127167003 | 12716700 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127167003 | 12716700 | Drug abuse | |
| 127167003 | 12716700 | Intentional self-injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |